Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Enrolling by invitation Not applicable

Factors Affecting Outcomes of Using Diode Laser Both 980 nm Wave Length and 450 Wavelength on Benign Laryngeal Lesions in Comparison to Traditional Cold Instrumentations as Regard Parameters of Laser Device, Nature of Lesion and Patient Factors

NCT06912945 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-10-01
Last updated
2025-08-24

Condition(s) studied

Benign Laryngeal Lesion

Investigational drug(s) / intervention(s)

using diode laser 980nm wavelength in benign laryngeal lesionsusing diode laser 450nm wavelength in benign laryngeal lesionsusing traditional cold instrumentations in benign laryngeal lesions

using diode laser 980nm wavelength in benign laryngeal lesions: using diode laser 980nm wavelength in treatment of benign laryngeal lesions

using diode laser 450nm wavelength in benign laryngeal lesions: using diode laser 450nm wavelength in treatment of benign laryngeal lesions

using traditional cold instrumentations in benign laryngeal lesions: using traditional cold instrumentations in treatment of benign laryngeal lesions

Study summary

Studying the different Factors affecting the outcomes of using diode laser both 980 nm wave length and 450 wavelength on benign laryngeal lesions in comparison to traditional cold instrumentations

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: \- All patients with benign laryngeal lesions Exclusion Criteria: * patients presenting with or have history of malignant laryngeal lesion

Primary outcome measure(s)

  • change in voice handicap index Arabic version (VHI-Arabic) — 2 months after treatment
    change in Voice handicap index Arabic version from baseline before treatment and after treatment
  • change in voice acoustic analysis — 2 months after treatment
    change in voice acoustic analysis including change in jitter and shimmer values from baseline preoperative and 2 months after treatment

Trial sites (1)

FacilityCityRegionStatus
Sohag University Sohag Sohag Governorate
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06912945 on ClinicalTrials.gov ↗ ← All trials in Egypt